Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

<p>The National Cancer Institute intends to publish a Notice of Funding Opportunity (NOFO) to invite&nbsp;applications for&nbsp;advanced development and enhancement of emerging informatics technologies&nbsp;to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and cancer health disparities. As a component of the NCI's&nbsp;<a href="http://itcr.cancer.gov/" target="_blank" style="color: rgb(31, 107, 178);">Informatics Technology for Cancer Research</a>&nbsp;(ITCR) Program, this NOFO will focus on&nbsp;advancing emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale for why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from driving cancer research projects as well as the broader user community throughout the development process must be included.</p> <p><br></p> <p>This NOFO will invite applications for the enhancement and dissemination of emerging, user-friendly informatics technologies that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis will be on uniqueness and potential impact on cancer research. In addition, all projects proposed in response to this NOFO must involve the following general attributes:</p> <p><br></p> <ul> <li>Potential to advance driving cancer research projects and the cancer research field in general;</li> <li>Offers clear...